SEARCH RESULTS FOR: "Tag: BMY"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2019(8)
2018(7)
2017(16)
2016(18)
2015(17)
2014(5)
CATEGORIES
Analyst Downgrades(5)
Analyst Update(6)
Analyst Upgrades(3)
Buzz Stocks(8)
By the Numbers(2)
Earnings Preview(1)
Expectational Analysis(1)
General(14)
Indicator of the Week(1)
Intraday Option Activity(8)
Midday Market Check(6)
Most Active Options Update(1)
Opening View(4)
Stock Market News(6)
Stocks On the Move(13)
Technical Analysis(1)
The Week Ahead(1)
Trader Content(1)
Unusual Trading Activity(1)
Analysts Upgrade Drug Stocks HZNP and BMY
https://www.schaeffersresearch.com/content/news/2019/08/14/analysts-upgrade-drug-stocks-hznp-and-bmy
8/14/2019 10:00 AM
Two names enjoying positive analyst attention this morning are drug concerns Horizon Pharma PLC (NASDAQ:HZNP) and Bristol-Myers Squibb Co (NYSE:BMY). Here's how the shares of HZNP and BMY stocks are...
Dow Edges Up; Gold Pops on U.S.-Iran Tensions
https://www.schaeffersresearch.com/content/ezines/2019/06/24/dow-edges-up-gold-pops-on-us-iran-tensions
6/24/2019 11:55 AM
The Dow Jones Industrial Average (DJI) is trading in positive territory at midday, boosted by strong gains for blue chips Goldman Sachs (GS) and Verizon (VZ). The intraday upside is modest, though,...
Big Money Volatility Trader Targets Bristol-Myers Squibb Stock
https://www.schaeffersresearch.com/content/options/2019/03/01/big-money-volatility-trader-targets-bristol-myers-squibb-stock
3/1/2019 2:05 PM
It's been a volatile stretch for Bristol-Myers Squibb Co (NYSE:BMY), per the stock's 60-day historical volatility of 40.5%, which registers in the 90th annual percentile. Today, one options trader ap...
Drug Stock Dives 67% on Disappointing Data
https://www.schaeffersresearch.com/content/news/2019/02/28/drug-stock-dives-67-on-disappointing-data
2/28/2019 3:36 PM
Stocks are trading lower today, after the U.S.-North Korea summit ended without a resolution. Among individual names making notable moves are healthcare stocks Novavax, Inc. (NASDAQ:NVAX), Celgene C...
Pharma Stock Sinks After Pulling Lung Cancer Treatment
https://www.schaeffersresearch.com/content/news/2019/01/24/pharma-stock-sinks-after-pulling-lung-cancer-treatment
1/24/2019 9:24 AM
The shares of Bristol-Myers Squibb Co (NYSE:BMY) are down 3% in electronic trading, after the pharma name pulled the U.S application for its combo lung cancer treatment of Opdivo and Yervoy. This come...
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center